PL4023651T3 - Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca - Google Patents

Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca

Info

Publication number
PL4023651T3
PL4023651T3 PL22153273.2T PL22153273T PL4023651T3 PL 4023651 T3 PL4023651 T3 PL 4023651T3 PL 22153273 T PL22153273 T PL 22153273T PL 4023651 T3 PL4023651 T3 PL 4023651T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
same
optically active
phenol derivative
pyranochromenyl phenol
Prior art date
Application number
PL22153273.2T
Other languages
English (en)
Inventor
Sang Ku Yoo
Jin Wook Chung
In Geun Jo
Ji Young Kim
Jeong Ho Lim
Ku Suk Kang
Jin Young Kim
Original Assignee
Glaceum, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaceum, Inc. filed Critical Glaceum, Inc.
Publication of PL4023651T3 publication Critical patent/PL4023651T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL22153273.2T 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca PL4023651T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20160081674 2016-06-29

Publications (1)

Publication Number Publication Date
PL4023651T3 true PL4023651T3 (pl) 2024-02-19

Family

ID=60787377

Family Applications (2)

Application Number Title Priority Date Filing Date
PL17820539.9T PL3480200T3 (pl) 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca
PL22153273.2T PL4023651T3 (pl) 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL17820539.9T PL3480200T3 (pl) 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca

Country Status (17)

Country Link
US (2) US20190152984A1 (pl)
EP (2) EP4023651B1 (pl)
JP (2) JP2019520381A (pl)
KR (1) KR102388965B1 (pl)
CN (1) CN109476676B (pl)
AU (1) AU2017287746B2 (pl)
BR (1) BR112018077392A2 (pl)
CA (1) CA3028954C (pl)
DK (1) DK4023651T3 (pl)
ES (2) ES2929931T3 (pl)
IL (1) IL263826B2 (pl)
MX (1) MX2018016361A (pl)
PL (2) PL3480200T3 (pl)
SG (1) SG11201811796SA (pl)
TW (1) TWI731998B (pl)
WO (1) WO2018004263A1 (pl)
ZA (1) ZA201900121B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2881000T3 (es) * 2016-10-04 2021-11-26 Glaceum Inc Método para la preparación de un derivado de 3-fenil-2,3,4,8,9,10-hexahidropirano[2,3-f]cromeno, isómeros ópticos del mismo e intermedios del proceso
KR20200105198A (ko) 2019-02-28 2020-09-07 주식회사 글라세움 신경계 질환의 예방 또는 치료용 약학적 조성물
WO2022260434A1 (ko) 2021-06-08 2022-12-15 주식회사 글라세움 자가면역 질환의 예방 또는 치료용 약학적 조성물
KR20240078928A (ko) * 2022-11-28 2024-06-04 가톨릭대학교 산학협력단 침샘 오가노이드 안정화 및 침샘조직 재생 유도 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL160964A0 (en) * 2001-10-11 2004-08-31 Kaneka Corp Peroxisome proliferator activated receptor ligand and process for producing the same
TW200513194A (en) * 2003-07-31 2005-04-16 Kaneka Corp Fat and oil processed composition for prevention and/or amelioration of life-style related disease
KR20070052211A (ko) * 2005-11-16 2007-05-21 주식회사 엠디바이오알파 글라브리딘을 유효성분으로 함유하는 질환 증후군 예방 및치료용 조성물
KR102344479B1 (ko) * 2013-12-24 2021-12-29 주식회사 글라세움 피라노크로메닐페놀 유도체, 및 대사증후군 또는 염증 질환 치료용 약학 조성물
KR101742274B1 (ko) 2014-12-31 2017-06-01 주식회사 과학기술분석센타 소규모 상수시설 통합 관리 시스템의 수질 측정 장치
ES2881000T3 (es) * 2016-10-04 2021-11-26 Glaceum Inc Método para la preparación de un derivado de 3-fenil-2,3,4,8,9,10-hexahidropirano[2,3-f]cromeno, isómeros ópticos del mismo e intermedios del proceso

Also Published As

Publication number Publication date
MX2018016361A (es) 2019-09-16
EP4023651B1 (en) 2023-09-13
KR20180002539A (ko) 2018-01-08
WO2018004263A1 (ko) 2018-01-04
CA3028954C (en) 2020-10-27
ES2964146T3 (es) 2024-04-04
IL263826A (en) 2019-01-31
PL3480200T3 (pl) 2023-01-30
EP3480200B1 (en) 2022-10-19
BR112018077392A2 (pt) 2019-04-09
JP2019520381A (ja) 2019-07-18
EP3480200A1 (en) 2019-05-08
KR102388965B1 (ko) 2022-04-22
US11332475B2 (en) 2022-05-17
CN109476676A (zh) 2019-03-15
TWI731998B (zh) 2021-07-01
DK4023651T3 (da) 2023-11-20
EP4023651A1 (en) 2022-07-06
US20190152984A1 (en) 2019-05-23
US20210094967A1 (en) 2021-04-01
ES2929931T3 (es) 2022-12-05
CN109476676B (zh) 2021-09-17
JP2020186259A (ja) 2020-11-19
JP7036871B2 (ja) 2022-03-15
EP3480200A4 (en) 2020-02-26
ZA201900121B (en) 2023-04-26
TW201808961A (zh) 2018-03-16
CA3028954A1 (en) 2018-01-04
NZ749461A (en) 2020-08-28
IL263826B1 (en) 2023-01-01
AU2017287746B2 (en) 2020-04-09
IL263826B2 (en) 2023-05-01
SG11201811796SA (en) 2019-02-27
AU2017287746A1 (en) 2019-01-17

Similar Documents

Publication Publication Date Title
HK1251153A1 (zh) 一種藥物組合物及其應用
EP3094343A4 (en) Rapid action insulin formulations and pharmaceutical delivery systems
HK1252026A1 (zh) 藥物組合及其應用
EP3233111A4 (en) Pharmaceutical composition comprising plasminogen and uses thereof
EP3434285A4 (en) PHARMACEUTICAL COMPOSITION AND USES THEREOF
EP3297640A4 (en) Pharmaceutical co-crystal composition and use thereof
ZA201900121B (en) Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same
DK3554534T3 (da) Farmaceutisk sammensætning omfattende insulin
EP3285758A4 (en) Co-crystal composition and its pharmaceutical use
EP3324954A4 (en) AMINONAPTHOCHINONE COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR BLOCKING A UBIQUITINATION PROTEASOM SYSTEM FOR DISEASES
PT3202759T (pt) Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo
IL263040A (en) Pharmaceutical composition comprising eteplirsen
EP3328368A4 (en) COMPOUNDS AND PHARMACEUTICAL COMPOSITION ASSOCIATED WITH UBIQUITINATION-PROTEASOME SYSTEM
HK1245113A1 (zh) 藥物組合物及其用途
IL257621B (en) A catechol derivative and a pharmaceutical preparation that includes it
EP3497080A4 (en) PHARMACEUTICAL FORMULATIONS AND THEIR USE
IL260321B (en) A multi-antigenic structure and a pharmaceutical preparation containing it
GB201519644D0 (en) Therapy and pharmaceutical composition
EP3454851A4 (en) COMPOSITIONS COMPRISING SUBSTITUTED BENZOFUROQUINOLIZINE AND A PSYCHOACTIVE MEDICINE
HUE057830T2 (hu) Famitinib tartalmú gyógyszerkészítmény
SG11201700122TA (en) Pharmaceutical compound comprising 13 glycerides, formulation and application thereof
IL264083A (en) A pharmaceutical preparation containing benzydamine
AU2015902260A0 (en) Pharmaceutical Combination and Uses Thereof